PDCD1 and cancer: Targeting IFN-α to the tumor cells but not the OT-1 T cells was necessary for the enhanced OT-1 killing against OVA expressing cancer cells since an anti-PD-1-IFN-α fusion at 1pM showed no activity in this assay (Fig 3C).